Hepatitis C Virus Infection and Outcome of Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3127-3130

  Ridruejo, E ^a   Cusumano, A ^a   Diaz, C ^a   Davalos Michel M ^a   Jost, L ^a   Mando O G ^a   Vilches, A ^a  

^a h ) L   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 37049025787     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.04.023     Document Type: Article

References (26)

1. Camps D.H., Azcona S., Bertola S., et al. Prevalencia de anticuerpos anti-hepatitis por virus C en hemodializados crónicos. Medicina (B Aires) 52 (1992) 511
2. Pereira B.J.G., and Levey A.S. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51 (1997) 981
3. Vosnides G. Hepatitis C in renal transplantation. Kidney Int 52 (1997) 843
4. Sypsa V., Psichogiou M., Katsoulidou A., et al. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 45 (2005) 334
5. Jadoul M., Poignet J.L., Geddes C., et al., HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 19 (2004) 904
6. Ridruejo E, Brunet M del R, Cusumano A, et al: HBsAg as predictor of outcome in renal transplant patients. Medicina (B Aires) 64:429, 2004
7. Einollahi B., Hajarizadeh B., Bakhtiari S., et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 18 (2003) 836
8. Mahmoud I.M., Elhabashi A.F., Elsawy E., et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 43 (2004) 131
9. Aroldi A., Lampertico P., Montagnino G., et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 79 (2005) 1132
10. Bruchfeld A., Wilczek H., and Elinder C.G. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation 78 (2004) 745
11. Manga Sahin G., Sahin S., Kantarci G., et al. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation. Transplant Proc 38 (2006) 499
12. Bestard O., Cruzado J.M., Torras J., et al. Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival. Transplant Proc 37 (2005) 3774
13. Aroldi A., Lampertico A., Elli A., et al. Long term evolution of antiHCV positive renal transplant recipients. Transplant Proc 30 (1998) 2076
14. Fabrizi F., Martin P., Dixit V., et al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5 (2005) 1452
15. Zylberberg H., Nalpas B., Carnot F., et al. Severe evolution of chronic hepatitis C in renal transplantation: A case control study. Nephrol Dial Transplant 17 (2002) 129
16. Kamar N., Selves J., Sandres-Saune K., et al. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?. Transplant Proc 38 (2006) 1329
17. Fabrizi F., Bromberg J., Elli A., et al. Review article: hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther 22 (2005) 657
18. Morales J.M. Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc 36 (2004) 760
19. Russo M.W., Goldsweig C.D., Jacobson I.M., et al. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 98 (2003) 1610
20. Fabrizi F., Dulai G., Dixit V., et al. Metaanalysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 18 (2003) 1071
21. Kokoglu O.F., Ucmak H., Hosoglu S., et al. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 21 (2006) 575
22. Sporea I., Popescu A., Sirli R., et al. Pegylated-interferon alpha 2a treatment for chronic hepatitis C patients on chronic hemodialysis. World J Gastroenterol 12 (2006) 4191
23. Russo M.W., Ghalib R., Sigal S., et al. Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant 21 (2006) 437
24. Annicchiarico B.E., and Siciliano M. Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther 20 (2004) 123
25. Chan T.M., Ho S.K.N., Tang C.S.O., et al. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection. Nephrology 12 (2007) 11
26. Casanovas-Taltavull T., Baliellas C., Benasco C., et al. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol 96 (2001) 1170